关键信息
-
基因名
IAH1
- 应用
-
别名
IAH1；Isoamyl acetate-hydrolyzing esterase 1 homolog
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q2TAA2
-
表达区间
1-248aa
-
氨基酸序列
MALCEAAGCG SALLWPRLLL FGDSITQFSF QQGGWGASLA DRLVRKCDVL NRGFSGYNTR WAKIILPRLI RKGNSLDIPV AVTIFFGAND SALKDENPKQ HIPLEEYAAN LKSMVQYLKS VDIPENRVIL ITPTPLCETA WEEQCIIQGC KLNRLNSVVG EYANACLQVA QDCGTDVLDL WTLMQDSQDF SSYLSDGLHL SPKGNEFLFS HLWPLIEKKV SSLPLLLPYW RDVAEAKPEL SLLGDGDH
-
分子量
27.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
IAH1, an important protein involved in various cellular processes, has garnered significant interest in the field of molecular biology and biotechnology. Initially identified as a key player in inflammatory responses, IAH1 has also been implicated in modulating immune responses and cellular signaling pathways. Researchers are particularly focused on the recombinant expression of IAH1 to study its functional properties and potential therapeutic applications. The ability to produce this protein in a controlled environment facilitates the exploration of its role in disease mechanisms, especially autoimmune disorders and cancers. Additionally, understanding the structure-function relationships of IAH1 could lead to the development of novel drug candidates aimed at targeting related pathways. The advancements in recombinant protein technologies, including the use of genetically engineered organisms, have provided new opportunities for large-scale production and analysis of IAH1. Consequently, ongoing studies aim to elucidate the detailed biochemistry of IAH1 and assess how its manipulation might benefit therapeutic interventions, making it a focal point in both academic research and pharmaceutical development.
